Navigation Links
Gene therapy increases survival for end-stage head and neck cancer
Date:5/28/2008

ctively in the phase III trial, with results related to biomarker status blinded until final data analysis.

If a tumor expresses high or low levels of normal p53, or a very low level of mutant p53, conditions are favorable for Advexin. Tumors with high levels of mutant p53 do not respond well to p53-related therapy. The healthy and mutant p53 biomarkers are easily discerned with standard lab techniques, Roth said immunohistochemical staining detects protein levels, while gene chip analysis reveals gene sequence.

Creation of Introgen

Roth found little interest in gene therapy from established pharmaceutical companies, so in 1994 he co-founded Introgen working through M. D. Anderson's Office of Technology Management.

Introgen has since grown into a publicly traded company on NASDAQ, and while it still licenses important technology from M. D. Anderson, the company works broadly with other medical research institutions and biotech firms.

Introgen developed a commercial-grade version of the drug and advanced it through phase II and III clinical trials for head and neck cancer. Advexin(r) also is being tested in other cancers in a variety of clinical trials.

"If something's going to get to patients, it has to be commercialized," Roth said. The National Cancer Institute funds basic and translational research but simply cannot afford to fund large, late-stage clinical trials, he said.

Nanotechnology and p53

Roth and colleagues now focus on ways to deliver p53 and other tumor-suppressing genes systemically - through intravenous delivery. Advexin has to be injected straight into the tumor, but that's not workable for many cancers. Head and neck cancer kills patients by recurring, not spreading to other organs, but most cancer deaths involve metastasis.

By wrapping tumor-suppressing genes in tiny balls of fat, Roth and colleagues hope to be able to treat more invasive cancers. Whil
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2 3 4

Related medicine news :

1. Vision restoration therapy shown to improve brain activity in brain injured patients
2. HIV therapy in pregnancy-data support WHO recommendations
3. Family-based treatment more effective than supportive psychotherapy in treating bulimia
4. Trial to Test Gene Therapy for Angina in Women
5. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
6. Aromatherapy Gift Line Sheds Humorous Light on Modern Therapy
7. Chemotherapy may be culprit for fatigue in breast cancer survivors
8. Atlanta Falcons Physical Therapy Centers Set to Launch This Fall
9. New Drug No Substitute for Standard Blood-Clot Therapy
10. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
11. Nucletron Announces Management Buy-Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene therapy increases survival for end-stage head and neck cancer
(Date:6/3/2015)... June 03, 2015 Alberto Grignolo, PhD, ... DIA’s upcoming Annual Meeting. DIA’s Global Inspire Award program ... of excellence, and commitment to service on a global ... Connector Award that annually recognizes one DIA member for ... the mission of DIA to foster innovation to improve ...
(Date:6/3/2015)... CT (PRWEB) June 03, 2015 Z-Medica®, ... announces today since June has been designated as National ... commends the Tucson, AZ. Police Department for its commitment ... its personnel utilized their Individual First Aid Kits (IFAK) ... civilians involved in shootings, stabbings or traffic accidents. Each ...
(Date:6/3/2015)... 03, 2015 Sitting at a computer ... in the back, neck, shoulders and/or wrists. This can ... In addition, recent research links sitting for long periods ... diseases. Fortunately, three inventors from Oakville, Ontario, are offering ... desk. , They have developed a prototype for a ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Implant design ... the osseointegration processes that unites bone to an implant ... portion has been designed to encourage bone regeneration, resulting ... support of stable surrounding soft tissues for more esthetic ... Ginat, Product Manager at MIS Implants. The triangular neck ...
(Date:6/3/2015)... ON (PRWEB) June 03, 2015 On ... a Marketing Authorization (MA), effective immediately, which now permits ... foods that contain oats as ingredients. The MA is ... being developed. All stakeholders should be aware that, unlike ... in the USA, there are restrictions for gluten-free oat ...
Breaking Medicine News(10 mins):Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 3Health News:Z-Medica Commends Tucson Police Department for Trauma Kit Utilization 2Health News:Adjustable Height Tabletop Unit Invented by Three InventHelp® Clients (TOR-9278) 2Health News:MIS Implants Launches Radically New V3 Dental Implant For Immediate Biological Benefits 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 3
... Reporter , TUESDAY, Oct. 26 (HealthDay News) -- Eating even ... such as salmon and other fatty fish, may help ward ... nearly 9,200 adults aged 20 and up participating in the ... into three groups based on their consumption of omega-3 fatty ...
... receive intensity modulated radiation therapy (IMRT) are less apt ... those who receive three-dimensional conformal radiotherapy (CRT), according to ... Medicine. The study, which will be presented Nov. 1 ... for Radiation Oncology (ASTRO) in San Diego, found that ...
... In the 15 minutes a primary care doctor typically has ... help manage ongoing health issues and provide preventive care. In ... mental health needs of patients is an ongoing challenge. ... Health System, however, points to an encouraging strategy for improving ...
... Amanda Gardner HealthDay Reporter , MONDAY, Oct. 25 ... to detect ulcers, cancer and other conditions -- may be ... most of the problems reported were minor, such as abdominal ... lower than previously suspected, according to a study published in ...
... genetic code of a sudden death cardiac killer. ... program in which people with no symptoms, but with a ... internal cardiac defibrillators (ICDs) which can restart their hearts if ... targeted genetic screening and individualized therapy that is significantly improving ...
... some of it unjustified are common among the caregivers ... according to the results of a small study from the ... and simple information, the researchers add. The study,s ... underscore the need for healthcare staff to do a better ...
Cached Medicine News:Health News:Fish Oil Might Help Fight Gum Disease 2Health News:Fish Oil Might Help Fight Gum Disease 3Health News:Targeted radiation therapy minimizes GI side effects for prostate cancer patients, Penn study shows 2Health News:Follow-ups prove powerful tool for treating depression in primary care 2Health News:GI Endoscopy Complication Rates Higher Than Suspected: Study 2Health News:GI Endoscopy Complication Rates Higher Than Suspected: Study 3Health News:Newfoundland researchers crack the genetic code of a sudden death cardiac killer 2Health News:Knowledge gaps, fears common among parents of children with drug-resistant bacteria 2Health News:Knowledge gaps, fears common among parents of children with drug-resistant bacteria 3
(Date:6/3/2015)... Conn. , June 3, 2015  SurgiQuest®, ... innovative access technologies for minimally invasive surgery (MIS) ... AirSeal® System in over 250,000 procedures.  Adoption has ... procedures over last year, driven by the company,s ... as well as geographic expansion to over 45 ...
(Date:6/3/2015)... -- Research and Markets  ( http://www.researchandmarkets.com/research/rf4hfn/global ) has ... Diseases Market 2015-2019" report to their offering. ... grow at a CAGR of 4.77% over the ... present scenario and the growth prospects of the ... To calculate the market size, the report considers ...
(Date:6/3/2015)... CAMBRIDGE, Mass. , June 3, 2015  EIP ... dosing in phase 2 clinical development of VX-745 in ... brain penetrant, highly selective and potent inhibitor of the ... protein kinase (p38 MAPK alpha). "Recent human ... of disease in patients with symptomatic Alzheimer,s, while the ...
Breaking Medicine Technology:Rapid Procedure Growth With SurgiQuest's AirSeal System 2Global Neurodegenerative Diseases Market 2015-2019 - Reformulation of Marketed Drugs 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 3
... , April 26 Sirion Therapeutics, Inc., a ... ophthalmic gel) 0.15% is now commercially available.  Zirgan™, which was ... September 2009 , is a topical ophthalmic antiviral indicated for ... , , ...
... TARRYTOWN, N.Y. , April 26 Bayer Diabetes ... blood glucose monitoring system in the United States . ... the only blood glucose meter that connects directly to Nintendo ... kids manage a lifelong disease by rewarding them for building ...
Cached Medicine Technology:Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes 2Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes 3Bayer Diabetes Care Introduces DIDGET In the US 2Bayer Diabetes Care Introduces DIDGET In the US 3Bayer Diabetes Care Introduces DIDGET In the US 4Bayer Diabetes Care Introduces DIDGET In the US 5
... test and the fully automated ... facts conveniently available when and ... the patient can be carried ... Test Cartridge contains all reagents ...
... 30 seconds. Be ready with the ... Emergency Medicine. Sonix CEP provides Emergency ... in a compact, portable system that ... on rechargeable battery up to 30 ...
Code-Ready defibrillator a defibrillator designed to provide clinicians with comprehensive support for resuscitation....
The Vivid e delivers everything you need in a compact echo system, like complete cardiovascular functionality, a comprehensive cardiac measurement and analysis package, and full shared service capabi...
Medicine Products: